Insider Trading
Current insider transactions (SEC Form 4) — buys and sells by officers, directors, and major shareholders.
| Ticker | Insider | Title | Date | Transaction | Price ($) | Shares | Value ($) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| RNA | Younis Husam | Chief Scientific Officer | 09/18/2026 | Steuer-Abgabe | 8.95 | 11,216 | 100,383 | Form 4 |
| RNA | Hughes Steven George | Chief Medical Officer | 09/18/2026 | Steuer-Abgabe | 8.95 | 21,459 | 192,058 | Form 4 |
| RNA | Flanagan W. Michael | Director | 09/18/2026 | Steuer-Abgabe | 8.95 | 22,812 | 204,167 | Form 4 |
| RNA | Boyce Sarah | Director | 09/18/2026 | Steuer-Abgabe | 8.95 | 126,418 | 1,131,441 | Form 4 |
| RNA | Kenney Stephanie | See Remarks | 09/18/2026 | Steuer-Abgabe | 8.95 | 2,375 | 21,256 | Form 4 |
| RNA | Gallagher Kathleen P. | See Remarks | 09/18/2026 | Steuer-Abgabe | 8.95 | 11,632 | 104,106 | Form 4 |
| RNA | Winslow Brendan R. | Chief Financial Officer | 09/18/2026 | Steuer-Abgabe | 8.95 | 6,742 | 60,341 | Form 4 |
| RNA | Hoyos Rocio Martin | Chief Strategy Officer | 09/18/2026 | Steuer-Abgabe | 8.95 | 8,320 | 74,464 | Form 4 |
A compact market overview — not investment advice. Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q).